Proposed diagnostic criteria for neurocysticercosis

Neurology

Volumn 57, Issue 2, 2001, Pages 177-183

  Del Brutto, Oscar H ^a,p   Rajshekhar, V ^b   White Jr , A C ^c   W Tsang, V C ^d   Nash, T E ^e   Takayanagui, O M ^f   Schantz, P M ^d   W Evans, C A ^g   Flisser, A ^h   Correa, D ^h   Botero, D ^j   Allan, J C ^k   Sarti, E ⁱ   Gonzalez, A E ^l,m   Gilman, R H ^m,n,o   Garcia H H ^m,o  

^a HOSPITAL CLÍNICA KENNEDY   (Ecuador)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

ⁱ SECRETARÍA DE SALUD   (Mexico)

^j Instituto Colombiano de Medicina Tropical   (Colombia)

^k PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^l UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^m ASOCIACIÓN BENÉFICA PRISMA   (Peru)

ⁿ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^o UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^p Air Center 3542   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; PARASITE ANTIBODY; PRAZIQUANTEL;

ANTIBODY DETECTION; BRAIN BIOPSY; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; IMAGING; NEUROCYSTICERCOSIS; PARASITE IDENTIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TAENIA SOLIUM;

EID: 0035943057     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.2.177     Document Type: Review

References (63)

1. Cysticercosis and neurocysticercosis in Africa: Current status
2. Neurocysticercosis: A major cause of neurological disease worldwide
3. Neurocysticercosis in Mexico
4. Cysticercosis cerebri: A review of 127 cases
5. Cysticercosis in Los Angeles county
6. Neurocysticercosis in Houston, Texas. A report of 112 cases
7. Neurocysticercosis: A special problem in the southwestern United States
8. Relationship between epilepsy and tropical diseases
9. MR imaging in neurocysticercosis: A study of 56 cases
10. Laboratory diagnosis of cysticercosis
11. Serological studies using ELISA and EITB in patients with solitary cysticercus granuloma and seizures
12. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis
13. Solitary cysticercus granuloma of the brainstem. Report of four cases
14. Diagnosis of human neurocysticercosis in endemic countries: A clinical study in Honduras
15. Letter to the editor
16. Neurocysticercosis
17. Parenchymal neurocysticercosis: Follow-up and staging by MRI
18. MR imaging of intracranial cysticercosis: Comparison with CT and anatomopathologic features
19. Ophthalmic cysticercosis
20. Neurocysticercosis: Correlative pathomorphology and MR imaging
21. Case 24-200
22. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium)
23. Diagnosis of cysticercosis in endemic regions
24. Serologic evolution of neurocysticercosis patients after antiparasitic therapy
25. Immunoblot diagnostic test (EITB) for Taenia solium cysticercosis and its contribution to the definition of this under-recognized but serious public health problem
26. Demonstration of species-specific and cross-reactive components of Taenia solium metacestode antigens
27. Species specific immunodiagnosis of Taenia solium by ELISA and immunoblotting
28. Comparative evaluation of purified Taenia solium glycoproteins and crude metacestode extracts by immunoblot for the serodiagnosis of human Taenia solium cysticercosis
29. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients with seizures
30. Intraparenchymal cerebral cysticercosis in children: Diagnosis and treatment
31. Single parenchymal brain cysticercus in the acute encephalitic phase: Definition of a bening form of neurocysticercosis with a benign prognosis
32. Single small enhancing CT lesion in Thai patients with acute symptomatic seizures: A clinico-radiological study
33. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis
34. Short course albendazole treatment for neurocysticercosis in Columbia
35. Albendazole therapy for neurocysticercosis: A prospective double-blind trial comparing 7 versus 14 days of treatment
36. Single-day praziquantel vs 1-week albendazole for neurocysticercosis
37. The use of albendazole in patients with single lesions enhanced on contrast CT
38. Albendazole therapy in children with focal seizures and single small enhancing computarized tomographic lesions: A randomized, placebo-controlled, double-blind trial
39. Mechanisms of hydrocephalus in cerebral cysticercosis: Implications for therapy
40. Neurocysticercosis. A new classification based on active and inactive forms
41. Epilepsy due to neurocysticercosis. An analysis of 203 patients
42. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico
43. Etiology of epilepsy: A prospective study of 210 cases
44. Late-onset epilepsy in Ecuador: Aetiology and clinical features in 225 patients
45. Cysticercosis as a major cause of epilepsy in Perú
46. ELISA antibodies to cysticerci of Taenia solium in human populations in New Guinea, Oceania, and Southeast Asia
47. New approaches in the diagnosis of Taenia solium cysticercosis and taeniasis
48. Cysticercose et neurocysticercose: Enquête épidémiologique dans le nord du Togo
49. The neurocysticercosis project in Atteridgeville: Mamelodi townships
50. Immunodiagnosis of neurocysticercosis: Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients
51. ELISA in the diagnosis of neurocysticercosis
52. Anticysticercus antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis
53. Human neurocysticercosis: Comparison of monoclonal and polyclonal based EIA capture assays for the detection of parasite products in cerebrospinal fluid
54. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis
55. Cysticercosis as seen in the British Army with special reference to the production of epilepsy
56. Cysticercosis: An analysis and follow-up of 450 cases
57. Locally acquired neurocysticercosis: North Carolina, Massachusetts, and South Carolina, 1989-1991
58. Neurocysticercosis in an Orthodox Jewish community in New York city
59. Taeniasis and cysticercosis due to Taenia solium
60. Immunodiagnosis of taeniasis by coproantigen detection